Crossover randomized study comparing the efficacy and tolerability of preservative-free Tafluprost 0.0015% to Latanoprost 0.005% in patients with primary open-angle glaucoma

by Sherein M Hagras, Omar K H Al-Duwailah, Mona A Nassief, Ameera G Abdelhameed
Published 2021-01-01